An industry analysis on October 20th revealed that the number of clinical trials launched annually in Britain decreased by 41%...
Read moreRemdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc., were sent by the United...
Read moreAmgen's market forecast for 2022 explains how competition has led to healthcare cost savings and predicts that a sizable proportion...
Read morePeter Marks, a top official at the Food and Drug Administration, is not tasked with determining if the expense of...
Read moreOn October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen...
Read moreLate in September, the trade group Medicines for Europe wrote an open letter to the European Commission (EC) requesting that...
Read moreFollowing a decision by the Food and Drug Administration to broaden its authorization of reformulated shots from Moderna and partners...
Read moreThe Clinical Trials Environmental Impact Community of Interest (CoI) has been launched by The Pistoia Alliance, a global, non-profit alliance...
Read moreThe molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from...
Read moreA public-private partnership between UZ Ghent and Ziphius Vaccines, a firm producing vaccines and treatments based on self-amplifying RNA (saRNA),...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.